Literature DB >> 26891144

Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease.

Sean W Mateer1, Jocelle Cardona1, Ellen Marks1, Bridie J Goggin1, Susan Hua1, Simon Keely2.   

Abstract

The epithelial barrier is the first innate defense of the gastrointestinal tract and selectively regulates transport from the lumen to the underlying tissue compartments, restricting the transport of smaller molecules across the epithelium and almost completely prohibiting epithelial macromolecular transport. This selectivity is determined by the mucous gel layer, which limits the transport of lipophilic molecules and both the apical receptors and tight junctional protein complexes of the epithelium. In vitro cell culture models of the epithelium are convenient, but as a model, they lack the complexity of interactions between the microbiota, mucous-gel, epithelium and immune system. On the other hand, in vivo assessment of intestinal absorption or permeability may be performed, but these assays measure overall gastrointestinal absorption, with no indication of site specificity. Ex vivo permeability assays using "intestinal sacs" are a rapid and sensitive method of measuring either overall intestinal integrity or comparative transport of a specific molecule, with the added advantage of intestinal site specificity. Here we describe the preparation of intestinal sacs for permeability studies and the calculation of the apparent permeability (Papp) of a molecule across the intestinal barrier. This technique may be used as a method of assessing drug absorption, or to examine regional epithelial barrier dysfunction in animal models of gastrointestinal disease.

Entities:  

Mesh:

Year:  2016        PMID: 26891144      PMCID: PMC4781746          DOI: 10.3791/53250

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  24 in total

Review 1.  Antimicrobial peptides in innate immunity of the human intestine.

Authors:  Jan-Michel Otte; Karlheinz Kiehne; Karl-Heinz Herzig
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

2.  In vitro and ex vivo intestinal tissue models to measure mucoadhesion of poly (methacrylate) and N-trimethylated chitosan polymers.

Authors:  Simon Keely; Atvinder Rullay; Carolyn Wilson; Adrian Carmichael; Steve Carrington; Anthony Corfield; David M Haddleton; David J Brayden
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

3.  Chloride-led disruption of the intestinal mucous layer impedes Salmonella invasion: evidence for an 'enteric tear' mechanism.

Authors:  Simon Keely; Linda Feighery; Deirdre P Campion; Leah O'Brien; David J Brayden; Alan W Baird
Journal:  Cell Physiol Biochem       Date:  2011-12-14

4.  Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.

Authors:  Mark W Musch; Yunwei Wang; Erika C Claud; Eugene B Chang
Journal:  Dig Dis Sci       Date:  2013-01-18       Impact factor: 3.199

5.  Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.

Authors:  Sam Maher; Rory Kennelly; Victoria A Bzik; Alan W Baird; Xuexuan Wang; Desmond Winter; David J Brayden
Journal:  Eur J Pharm Sci       Date:  2009-09-06       Impact factor: 4.384

6.  Revised guides for organ sampling and trimming in rats and mice--part 1.

Authors:  Christine Ruehl-Fehlert; Birgit Kittel; Gerd Morawietz; Paul Deslex; Charlotte Keenan; Charles R Mahrt; Thomas Nolte; Mervyn Robinson; Barry P Stuart; Ulrich Deschl
Journal:  Exp Toxicol Pathol       Date:  2003-09

7.  An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine.

Authors:  L Barthe; J F Woodley; S Kenworthy; G Houin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.569

Review 8.  Hypoxia and Integrin-Mediated Epithelial Restitution during Mucosal Inflammation.

Authors:  Bridie J Goggins; Ciaran Chaney; Graham L Radford-Smith; Jay C Horvat; Simon Keely
Journal:  Front Immunol       Date:  2013-09-11       Impact factor: 7.561

9.  Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis.

Authors:  S Keely; E L Campbell; A W Baird; P M Hansbro; R A Shalwitz; A Kotsakis; E N McNamee; H K Eltzschig; D J Kominsky; S P Colgan
Journal:  Mucosal Immunol       Date:  2013-05-22       Impact factor: 7.313

10.  Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in ussing chambers.

Authors:  Dallin Hubbard; Hamidreza Ghandehari; David J Brayden
Journal:  Biomacromolecules       Date:  2014-07-03       Impact factor: 6.988

View more
  11 in total

1.  Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrity.

Authors:  Stephanie Oertel; Klaus Scholich; Andreas Weigert; Dominique Thomas; Julia Schmetzer; Sandra Trautmann; Marthe-Susanna Wegner; Heinfried H Radeke; Natalie Filmann; Bernhard Brüne; Gerd Geisslinger; Irmgard Tegeder; Sabine Grösch
Journal:  Cell Mol Life Sci       Date:  2017-04-12       Impact factor: 9.261

2.  Glycated milk protein fermented with Lactobacillus rhamnosus ameliorates the cognitive health of mice under mild-stress condition.

Authors:  Nam Su Oh; Jae Yeon Joung; Ji Young Lee; Jae Gwang Song; Sangnam Oh; Younghoon Kim; Hyung Wook Kim; Sae Hun Kim
Journal:  Gut Microbes       Date:  2020-06-23

3.  An Industrial Procedure for Pharmacodynamic Improvement of Metformin HCl via Granulation with Its Paracellular Pathway Enhancer Using Factorial Experimental Design.

Authors:  Omar Y Mady; Adam A Al-Shoubki; Ahmed A Donia
Journal:  Drug Des Devel Ther       Date:  2021-11-02       Impact factor: 4.162

4.  Precision targeting of the vagal anti-inflammatory pathway attenuates the systemic inflammatory response to burn injury.

Authors:  Todd W Costantini; Raul Coimbra; Jessica L Weaver; Brian P Eliceiri
Journal:  J Trauma Acute Care Surg       Date:  2022-02-01       Impact factor: 3.697

5.  Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction.

Authors:  Michael Fricker; Bridie J Goggins; Sean Mateer; Bernadette Jones; Richard Y Kim; Shaan L Gellatly; Andrew G Jarnicki; Nicholas Powell; Brian G Oliver; Graham Radford-Smith; Nicholas J Talley; Marjorie M Walker; Simon Keely; Philip M Hansbro
Journal:  JCI Insight       Date:  2018-02-08

6.  The enhanced intestinal permeability of infant mice enables oral protein and macromolecular absorption without delivery technology.

Authors:  John P Gleeson; Katherine C Fein; Namit Chaudhary; Rose Doerfler; Alexandra N Newby; Kathryn A Whitehead
Journal:  Int J Pharm       Date:  2020-11-26       Impact factor: 5.875

7.  Investigating Gut Permeability in Animal Models of Disease.

Authors:  Marianela González-González; Camilo Díaz-Zepeda; Johana Eyzaguirre-Velásquez; Camila González-Arancibia; Javier A Bravo; Marcela Julio-Pieper
Journal:  Front Physiol       Date:  2019-01-15       Impact factor: 4.566

8.  In vivo oral insulin delivery via covalent organic frameworks.

Authors:  Farah Benyettou; Nawel Kaddour; Thirumurugan Prakasam; Gobinda Das; Sudhir Kumar Sharma; Sneha Ann Thomas; Fadia Bekhti-Sari; Jamie Whelan; Mohammed A Alkhalifah; Mostafa Khair; Hassan Traboulsi; Renu Pasricha; Ramesh Jagannathan; Nassima Mokhtari-Soulimane; Felipe Gándara; Ali Trabolsi
Journal:  Chem Sci       Date:  2021-04-06       Impact factor: 9.825

9.  Nonlethal Plasmodium yoelii Infection Drives Complex Patterns of Th2-Type Host Immunity and Mast Cell-Dependent Bacteremia.

Authors:  Nora Céspedes; Erinn Donnelly; Sarah Garrison; Lori Haapanen; Judy Van De Water; Shirley Luckhart
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

10.  PARK7 Diminishes Oxidative Stress-Induced Mucosal Damage in Celiac Disease.

Authors:  Apor Veres-Székely; Mária Bernáth; Domonkos Pap; Réka Rokonay; Beáta Szebeni; István M Takács; Rita Lippai; Áron Cseh; Attila J Szabó; Ádám Vannay
Journal:  Oxid Med Cell Longev       Date:  2020-09-05       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.